Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05687994 · ClinicalTrials.gov registry record · NA
Speech Entrainment Treatment for People With Aphasia
A NA study, sponsored by Albert Einstein Healthcare Network.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT05687994 is a NA study that has completed, run by Albert Einstein Healthcare Network. The registered enrollment target is 30 participants.
The verdict
NCT05687994, a NA study, has completed, sponsored by Albert Einstein Healthcare Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The objective of this research is to experimentally delineate the direct effect of speech entrainment practice on independent speech production and identify practice conditions that enhance treatment benefits. The primary outcome measure (Correct Information Units per minute) tallies informativeness and efficiency of independent speech in treated stories.
Interventions
- BEHAVIORAL Audiovisual Speech Entrainment Practice
- BEHAVIORAL Auditory Speech Entrainment Practice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-01-25 |
| Est. Completion | 2025-05-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05687994
The ClinicalTrials.gov registry entry for NCT05687994 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein Healthcare Network, which has 48 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Audiovisual Speech Entrainment Practice is the first listed.
NCT05687994 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05687994 about?
NCT05687994 is a clinical study titled "Speech Entrainment Treatment for People With Aphasia". The objective of this research is to experimentally delineate the direct effect of speech entrainment practice on independent speech production and identify practice conditions that enhance treatment benefits. The primary outcome measure (Correct Information Units per minute) tallies informativeness...
What is the current status of trial NCT05687994?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2023-01-25. Estimated completion is 2025-05-29.
What interventions are being tested in trial NCT05687994?
The interventions under investigation include: Audiovisual Speech Entrainment Practice (BEHAVIORAL), Auditory Speech Entrainment Practice (BEHAVIORAL).
Who is sponsoring clinical trial NCT05687994?
This trial is sponsored by Albert Einstein Healthcare Network, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.